The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
Many adults in the United States regularly consumer energy drinks. Currently, the safety of energy drinks is still questionable and there are many reports associating energy drinks with adverse events including hospitalizations and deaths. Previous research shows that energy drink can affect heart rhythm and elevate blood pressure. However, these studies use a higher volume (32 ounces) of energy drinks than those available in the market (24 ounces). The purpose of this study is to study if 24-ounce energy drinks can significantly affect heart rhythm and elevate blood pressure when compared to a placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Feb 2019
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedStudy Start
First participant enrolled
February 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2019
CompletedSeptember 25, 2019
March 1, 2019
3 months
February 12, 2019
September 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
QTc interval
Maximum change in QTc interval from baseline in each of 2 arm
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
Central systolic blood pressure
Maximum change in central systolic blood pressure from baseline in each of 2 arm
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
Secondary Outcomes (7)
QT interval
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
PR interval
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
QRS duration
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
Heart rate
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
Central diastolic blood pressure
Measurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hours
- +2 more secondary outcomes
Study Arms (2)
Energy drink
EXPERIMENTALTwo 12 oz bottles of energy drink
Placebo
PLACEBO COMPARATORTwo 12 oz bottles of placebo drink
Interventions
Two 12 oz bottles placebo drink. Placebo drink will contain carbonated water, lime juice, and cherry flavoring.
Eligibility Criteria
You may qualify if:
- Healthy male or female adults 18-40 years old
- Participants must be willing to refrain from caffeine and alcohol use 48 hours prior to each study day
- Participants must be willing to fast 10 hours prior to each study day
- Participants must have health insurance
You may not qualify if:
- Corrected QT (QTc) interval greater than 450 milliseconds (ms). QTc will be determined on the ECG obtained during initial screening appointment.
- Blood pressure at initial screening appointment greater than 140/90 mmHg.
- Presence of any known medical condition confirmed through participant interview
- Concurrent use of ANY medication taken on a daily basis, to include herbal products or supplements (exception include oral contraceptives that will be allowed if taking for longer than 1 month)
- Current smokers or those who have smoked any cigarettes within the past month
- Pregnant or currently breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pacific
Stockton, California, 95211, United States
Related Publications (6)
Fletcher EA, Lacey CS, Aaron M, Kolasa M, Occiano A, Shah SA. Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters. J Am Heart Assoc. 2017 Apr 26;6(5):e004448. doi: 10.1161/JAHA.116.004448.
PMID: 28446495BACKGROUNDShah SA, Occiano A, Nguyen TA, Chan A, Sky JC, Bhattacharyya M, O'Dell KM, Shek A, Nguyen NN. Electrocardiographic and blood pressure effects of energy drinks and Panax ginseng in healthy volunteers: A randomized clinical trial. Int J Cardiol. 2016 Sep 1;218:318-323. doi: 10.1016/j.ijcard.2016.05.007. Epub 2016 May 13.
PMID: 27240158BACKGROUNDShah SA, Chu BW, Lacey CS, Riddock IC, Lee M, Dargush AE. Impact of Acute Energy Drink Consumption on Blood Pressure Parameters: A Meta-analysis. Ann Pharmacother. 2016 Oct;50(10):808-15. doi: 10.1177/1060028016656433. Epub 2016 Jun 23.
PMID: 27340146BACKGROUNDPhan JK, Shah SA. Effect of caffeinated versus noncaffeinated energy drinks on central blood pressures. Pharmacotherapy. 2014 Jun;34(6):555-60. doi: 10.1002/phar.1419. Epub 2014 Mar 19.
PMID: 24644139BACKGROUNDHajsadeghi S, Mohammadpour F, Manteghi MJ, Kordshakeri K, Tokazebani M, Rahmani E, Hassanzadeh M. Effects of energy drinks on blood pressure, heart rate, and electrocardiographic parameters: An experimental study on healthy young adults. Anatol J Cardiol. 2016 Feb;16(2):94-9. doi: 10.5152/akd.2015.5930. Epub 2015 Mar 23.
PMID: 26467367BACKGROUNDElitok A, Oz F, Panc C, Sarikaya R, Sezikli S, Pala Y, Bugan OS, Ates M, Parildar H, Ayaz MB, Atici A, Oflaz H. Acute effects of Red Bull energy drink on ventricular repolarization in healthy young volunteers: a prospective study. Anatol J Cardiol. 2015 Nov;15(11):919-22. doi: 10.5152/akd.2015.5791. Epub 2015 Mar 5.
PMID: 25868042BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Lee, PharmD
University of the Pacific
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2019
First Posted
February 15, 2019
Study Start
February 23, 2019
Primary Completion
May 9, 2019
Study Completion
May 9, 2019
Last Updated
September 25, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share